Joint WHO/UNAIDS annual consultation with pharmaceutical companies: Global forecasts of antiretroviral demand 2012-2013
Dates: 31 October - 1 November 2011
Place: Geneva, Switzerland
The main objectives of the meeting were to present and discuss global forecasts of antiretroviral demand in the next two years, and brief the pharmaceutical organizations on key HIV developments in WHO, UNAIDS and other partner organizations.
Documents
Presentations
Achieving universal access
-
Advancing Treatment 2.0: short and mid-term priorities for antiretroviral drug optimization
pdf, 1.11Mb -
Achieving universal access: Global guidance for innovation
pdf, 994kb -
Scaling up priority HIV/AIDS interventions in the health sector
pdf, 994kb
Forecasting
-
Forecasting demand for ARVs 2011 - 2013
pdf, 1.20Mb -
Market share of different ARV classes: observations from the Global Price Reporting Mechanism
pdf, 284kb -
WHO survey on ARV use 2011
pdf, 377kb
Resources to meet demand
-
Financing ART in low- and middle-income countries
pdf, 912kb -
PEPFAR’s contributions to the global scale-up of treatment
pdf, 1.61Mb -
UNITAID: Innovative financing mechanism
pdf, 750kb
Access to current products and innovation
-
Access to current products and innovation for the future
pdf, 536kb -
Access to current products and innovation for the future: Some community Thoughts
pdf, 63kb -
Bill & Melinda Gates Foundation: HIV treatment optimization
pdf, 645kb -
Treatment needs and strategies for young children
pdf, 1.98Mb -
Update on the Medicines Patent Pool
pdf, 848kb